Copart, Inc. CPRT
27.59
(0.45)
(1.60%)
as of 25 Sep
- Market cap
- $26.1B
- P/E
- 17.7×
Follow CPRT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Copart, Inc. (CPRT) Net income
Copart, Inc.'s net income for fiscal 2026 was $1.5B, unchanged from fiscal 2025. Over the past ten years it has ranged from $219.8M (fiscal 2015) to $1.5B (fiscal 2025); the current reading is higher than 92% of that period. Copart, Inc. ranks 4th of 42 Specialty Business Services companies by net income.
Net income, annual
Annual
| Period | Net income | Change |
|---|---|---|
| FY2026 | $1.5B | (4.39%) |
| FY2025 | $1.5B | 13.65% |
| FY2024 | $1.4B | 10.07% |
| FY2023 | $1.2B | 13.54% |
| FY2022 | $1.1B | 16.41% |
| FY2021 | $936.5M | 33.80% |
| FY2020 | $699.9M | 18.29% |
| FY2019 | $591.7M | 41.55% |
| FY2018 | $418.0M | 6.02% |
| FY2017 | $394.3M | 45.83% |
Quarterly
| Period | Net income | Change |
|---|---|---|
| Jul 2026 | $326.8M | (18.58%) |
| Apr 2026 | $401.4M | 14.69% |
| Jan 2026 | $350.0M | (12.99%) |
| Oct 2025 | $402.2M | 1.75% |
| 43 more quarters | Free account |
Against its own ten years
Low $219.8M
High $1.5B
Ten-year median
$818.2M
Current reading's percentile
92
Net income against peers
| Company | Net income |
|---|---|
| RELX RELX PLC compare | $11.8B |
| RTO Rentokil Initial PLC compare | $2.1B |
| CTAS Cintas Corporation compare | $2.1B |
| CPRT Copart, Inc. | $1.5B |
| ULS UL Solutions Inc. compare | $529.0M |
| ARMK Aramark compare | $383.7M |
| DLB Dolby Laboratories compare | $228.0M |
| AMTM Amentum Holdings, Inc. compare | $201.0M |
| UNF Unifirst Corporation compare | $115.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on CPRT
- Revenue
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement